FDA Approves a Dangerous New Antidepressant—for Hot Flashes! | The Alliance for Natural Health USA
See on Scoop.it – Health and Wealth News To Use
The agency defied its own panel’s recommendation against approval because slight benefit is not worth the risk of suicide (and, we might add, addiction).
Mellisa McJunkin‘s insight:
What the press release fails to mention is that the FDA’s Reproductive Health Drugs Advisory Committee voted 10 to 4 that the overall risk-benefit profile of the drug did not support approval—that the benefits over placebo were “minimal,” and that all of the severe side effects associated with SSRIs, such as suicidal thoughts and osteoporosis, outweigh the minor benefits.
See on www.anh-usa.org